| Literature DB >> 27340286 |
Joshua M Thurman1, Carla M Nester2,3.
Abstract
The complement (C) cascade is an ancient system of proteins whose primary role is to initiate and modulate immune responses. During C activation, circulating proteins are cleaved and nascent cleavage fragments participate in a broad range of downstream innate and adaptive immune functions. Although the majority of these functions are either homeostatic or protective, a large body of experimental and clinical evidence also highlights a central role for the C system in the pathogenesis of many types of glomerular disease. From classic pathway activation in lupus nephritis to alternative pathway dysregulation in C3 glomerulopathy, our understanding of the spectrum of C involvement in kidney disease has expanded greatly in recent years. However, the characteristics that make the glomerulus so uniquely susceptible to C-mediated injury are not fully understood, and this remains an area of ongoing investigation. Several C inhibitors have been approved for clinical use, and additional C inhibitory drugs are in development. The use of these drugs in patients with kidney disease will expand our understanding of the benefits and limitations of C inhibition.Entities:
Keywords: Complement Activation; Complement Inactivating Agents; Complement System Proteins; Humans; Kidney Diseases; Kidney Glomerulus; clinical immunology; complement; glomerular disease; glomerulonephritis; immune complexes; lupus nephritis
Mesh:
Substances:
Year: 2016 PMID: 27340286 PMCID: PMC5053787 DOI: 10.2215/CJN.01710216
Source DB: PubMed Journal: Clin J Am Soc Nephrol ISSN: 1555-9041 Impact factor: 8.237